Case of the month by Parker, Rochelle
Rise  (continued)  take charge of their own health.  Social efforts to stem health care costs and improve quality will not 
succeed until individual patients begin to make healthy lifestyle choices.  The introduction of EMR, while benefi-
cial is some areas, will have little effect on healthcare cost and quality without a significant shift in the attitude of 
our patient population. 
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CASE OF THE MONTH      ROCHELLE PARKER MD 
 
Case 1: A 10 year old developed pain in her right arm and a rash on her trunk and extremities; one month later 
(on October 3), she began vomiting and had increased pain in the arm with associated numbness.  Xrays of her 
arm and clavicle were normal.  Several days later, dysarthria was noted and the patient had decreased appetitie, 
sore throat and neck pain; she developed a fever of 101 F and had become agitated and irritable.  A rapid Group 
A strep test and heterophile antibody were negative.  She was hospitalized on October 7 at a community hospital 
and was found to have difficulty swallowing her secretions.  Her tongue was protruding and had a whitish 
coating; CBC and electrolytes were normal.  She was treated with methylprednisolone for possible glossitis  and 
fluconazole for presumed mucosal candidiasis. 
By October 8, neurologic involvement was evident and she was transferred to a tertiary center.  On arrival, she 
was noted to be irritable, intermittently alert and lethargic; she had slurred speech, had difficulty swallowing her 
secretions and complained of a drowning sensation.  Intubation was performed to control secretions and improve 
her oxygenation; she was placed on a ventilator.  An LP revealed 26 WBC/mm3, 1 RBC, protein 28 mg/dl and a 
glucose of 89 mg/dl.  Vancomycin, cefotaxime and acyclovir were started for presumed meningoencephalitis.  On 
the second day of admission, somnolence, generalized skin flushing and hypersalivation were noted. 
On further questioning, the patient’s mother reported that, in June, the patient had been awakened by a bat or 
bird that had flown into her room and bit or scratched her arm; the mother assumed that she had a nightmare 
and treated the scratch with an OTC product.  Approximately 3 days later, her brother took a dead bat from their 
cat.  After receiving this information, saliva, CSF and a skin biopsy from the nape of the neck were sent (cont)  
  
Page 5 
 
Rise  (continued) to the CDC, where genetic sequencing characterized the infecting agent as a rabies virus associated 
with the silver-haired bat.  Post exposure prophylaxis (PEP) was administered to all persons who had contact 
with the patient’s sputum from 7 days before the onset of her initial symptoms (a total of 66 persons, including 
family members, friends, health care workers and social contacts). 
The patient was treated with antiexcitatory and antiviral therapies, including phenobarbital, midazolam, keta-
mine and amantadine, in addition to aggressive supportive care.  On the sixth day of hospitalization, IV ribavirin 
was administered; coenzyme Q10, l-arginine tetrahydrobiopterin and vitamin C were administered in an attempt 
to replenish neurotransmitter substrates.  Multiple complications occurred, including increased ICP, bouts of DI, 
SIADH, pancreatitis secondary to ribavirin, intracranial venous sinus thrombosis and cerebral and cerebellar 
herniation.  The patient never regained consciousness, life support was withdrawn and she died on November 2, 
the 26th day of hospitalization. 
Case 2:  Two undergraduate university students presented to Student Health five days after they had rescued a 
kitten that had been left outside to die.  In the process of caring for it, both students were bitten; since the kitten 
seemed to be ill, it was taken to a vet, were it was immunized and treated with antibiotics.   The vet also noted 
that it had some sort of neurologic impairment and the kitten died three days later; its carcass was discarded in 
the trash.  Concerned, the students sought medical attention and were advised to receive rabies immunoglobulin 
and a series of post exposure immunizations; they were well and asymptomatic 18 months later. 
Case 3:  A 10 year old Philippino boy presented with a severe sore throat, fever and insomnia, for which he was 
treated with Amoxicillin.  Within 2 days, he became agitated, complained of chest tightness and developed 
dysphagia; he was admitted to the hospital where he demonstrated other signs of rabies infection: aerophobia, 
ydrophobia and profuse salivation and he was transferred to a tertiary care center.  There, his siblings reported 
that the patient had been bitten by a dog two years earlier, when living in the Philippines (his parents were not 
informed of the incident and he did not receive PEP).  Saliva samples were sent to the CDC and rabies virus RNA 
was detected by PCR.  A detailed hospital course is presented in the MMWR reference *1+.  Following multiple 
complications (autonomic instability, SIADH, renal failure, seizures, progressive heart block, cerebral edema), the 
patient died after support was withdrawn on the 27th hospital day.  A postmortem brain biopsy revealed the 
presence of rabies virus antigen. 
DISCUSSION:  Rabies virus belongs to the order Mononegavirales, viruses with a nonsegmented negative-
stranded RNA genome.  It has a distinct bullet shape and is classified in the Rhabdoviridae family, which 
includes at least three genera of animal viruses.  Genus Lyssavirus includes rabies virus found in bats. 
 
 
 
 
 
 
 
 
Rabies causes an acute encephalitis in all warm-blooded hosts which is almost always fatal.  All mammals are 
susceptible through only a few species are important reservoirs of the disease.  In the U.S., distinct rabies virus 
variants have been found in raccoons, skunks, foxes, coyotes and in several species of insectivore bats.  (cont) 
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Rise  (continued)  Transmission usually begins when infected saliva of the host is passed to an unifected animal; this 
may be via contamination of mucous membranes, corneal transplantation or, most commonly, via a bite from the 
infected  host.  The incubation phase in humans is highly variable with symptoms occurring between 10 days and 
1 year or more post inoculation.  Initial symptoms usually resemble a flu-like illness, which soon progresses to 
anxiety, confusion, agitation, abnormal ideation (such as fear of water), profuse salivation, delirium and halluci-
nations.  Once these symptoms develop, the disease is almost always fatal; treatment strategies, based on the 
Milwaukee Protocol which is credited with saving the life of a 15 year old rabies victim in 2004 *2+, have not 
proved to be effective.  CNS pathology includes perivascular infiltration of leukocytes and plasma cells and 
cytoplasmic eosinophilic inclusions (Negri bodies) in pyramidal cells of the hippocampus and Purkinje cells of 
the cerebellum; these inclusions have been identified as sites of active viral replication. 
Post Exposure Prophylaxis (PEP):  Rabies kills approximately 100,000 individuals worldwide, most of whom are 
children.  However, it is preventable with: 1. proper wound care (washing for at least 5 minutes with soap and 
water), 2. the administration of human rabies immune globulin before symptoms develop and 3. five doses of 
rabies vaccine over a 28 day period.  Every year, some 39,000 people receive PEP in the U.S. and, if given in time, 
it is 100% effective.  Pre-exposure PEP does not eliminate the need for post exposure treatment but simplifies the 
course by negating the need for rabies immune globulin and by shortening the vaccination course.  Rabies 
immune globulin provides rapid, passive immunity for a short time (its half-life is 21 days while the vaccine will 
induce active antibodies within 10 days that will persist for 2 years or more. 
EPIDEMIOLOGY:  Before 1960, most cases of rabies in the U.S. were secondary to the bite of domestic animals 
but is now usually due to wild animal bites.  It has been documented in all States except Hawaii and, over the 
past Century, U.S. deaths from rabies have fallen from >100/year to an average of 1-2/year.  The disease has been 
reported worldwide except for a few Caribbean islands, England, Ireland, Japan, Taiwan, Spain and Portugal.  
Rabies is a major problem in Asia, Africa, Central America and South America; exposure to rabid dogs accounts 
for over 90% of cases and 99% of deaths from this infection worldwide.  Vaccination of dogs in the U.S. costs over  
$300 million per year, an expense that is beyond reach in developing countries.  Most cases in the U.S. are now 
related to infection transfer from bats; those that are found to be active by day, are found in unusual locations or 
appear to be unable to fly are most likely to be rabid.  In Missouri, a girl was bitten by a bat last July; it was 
caught and found to be rabid and she was treated with PEP and has done well; the last fatal case in Missouri 
occurred in November, 2008, when a 55 year old male died at MU (he had not sought medical attention following 
a bat bite and did not receive PEP). 
Conclusion:  These cases demonstrate the importance of prompt medical attention following the bite from a 
potentially rabid animal.  The incubation period is highly variable and the initial presenting symptoms are often 
nonspecific and rather mild.  Failure to receive PEP following a bite from a rabid animal will almost always prove 
to be a fatal decision. 
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